Longenesis

Unlock Patient-Centric Solutions With Longenesis

Transform patient engagement, drive behavior change, and propel market access projects with Longenesis digital toolkit.

Explore more

Trusted by Global Leaders in Biopharma and Research

What we provide

Longenesis provides a digital platform for post-market research and patient engagement that bridges life-science companies, healthcare providers and patients.

Market access

Quick and targeted patient cohort identification for novel drug therapies and research activities

Adherence

Digital Patient Journeys to improve disease management, retention and build long-term relationships

Marketing activities

Launch population engagement projects to improve market uptake of innovative products

Data insights

Generate Real-World Evidence and Quality of Life data to support reimbursement negotiations

Let's collaborate!

Advancing Healthcare Through Specialized Therapeutic Areas

At the forefront of medical innovation, we are dedicated to improving patient outcomes across these critical therapeutic areas:

Cardiometabolic

Enhancing care for heart and metabolic health.
Oncology

Improving outcomes in cancer treatment and prevention.
Infectious diseases

Advancing solutions for infectious disease challenges.
Women's health

Focusing on specialized healthcare for women.

Read our success stories

Contact us today!

Ready to explore how our offerings can benefit your organization? Contact us to learn more about our available solutions and how they can address your requirements.

Tailored solutions

Our tailored solutions are designed to meet your specific needs, providing personalized strategies and services to optimize your outcomes.

750 000+

Patients Empowered Worldwide
20+

Partnerships with Healthcare
10+

Partnerships with Life Science industry
15

Academic publications

Success Stories

Longenesis is Leading Research into Respiratory Tract Infections in Children

Longenesis Partners with Ewopharma

With Longenesis's advanced Engage platform, the study on pediatric respiratory infections aims to streamline data collection and participant engagement while upholding the highest ethical standards. Stay tuned for results in February 2028.

Longenesis Tools Support the Creation of One of the World's Largest Data Biobanks

Longenesis partners with M42 Health

Since the start of the project in 2020 over 500,000 citizens across the UAE have participated in the "Emirati Genome Programme" with the help of Longenesis tools. This number is expected to reach over 1 million citizens by 2025.

Making Personalised Medicine More Accessible Across Europe with Dante Genomics

Longenesis Partners with Dante Genomics

Dante Genomics, a global leader in genomics and precision medicine, will offer whole genome sequencing (WGS) to more than 10,000 existing Longenesis study participants across the Baltics and Mediterranean regions.

More success stories:

How Longenesis Tools Help with Understanding Rare Skin Diseases

Clinical and Academic Centers in Hungary and the Baltics

Longenesis.Engage: A Key Support for Detecting and Understanding Long COVID Symptoms in Children

Children's Clinical University Hospital in Latvia

Our Clients Love Us

"Longenesis has been successfully implementing its products and declared value propositions with the projects under our administration in a timely and valuable manner, as well as successfully performing all necessary integrations with other technology vendors, laboratories, and National eID systems. Digitalized health data curation, thus, has provided time and cost savings, as well as compliance assurance for the actions involving obtaining the permissions for biomedical data use."

Ashish Koshy

CEO - G42 Healthcare

"Engage.Longenesis is a tool that every health care student/researcher who has ever "collected" patient data, compiled it, analyzed it, dreamed of. For data security purposes, the whole process was previously manual work by the researcher, which is very time-consuming. I got acquainted with the Engage.Longenesis tool/platform and I see that its application will facilitate and speed up the collection, compilation and analysis of patient data."

Guna Semjonova

Doctor of Philosophy - Ph.D.; Lecturer and Acting Research Assistant, Department of Rehabilitation Riga Stradins University

"I would like to express my gratitude to the Longenesis team for their responsiveness and contribution in executing the hereditary cancer screening pilot project with their digital solution! Although the pilot project has not yet ended, we have already obtained very valuable information that we will be able to use to further improve it. I can definitely recommend the Engage platform to other researchers!"

Dr. med. Arvids Irmejs

Head of the Pauls Stradiņš Clinical University Hospital Breast Disease Centre, Lead Researcher at the Institute of Oncology of Riga Stradiņš University

Commitment to compliance

Quality and security is at the heart of everything we do, and we continuously challenge ourselves to improve our services to meet or exceed the needs and expectations of our customers, while always complying with regulations and specifications.

GDPR

Our commitment to compliance extends to GDPR regulations. Rest assured, we are fully GDPR compliant, prioritizing data protection and privacy in all our processes and solutions.
ISO/IEC 27001

The ISO/IEC 27001 standard provides companies with guidance for establishing, implementing, maintaining and continually improving an information security management system.
ISO/IEC 27701

ISO/IEC 27701 specifies requirements and provides guidance for establishing, implementing, maintaining and continually improving a Privacy Information Management System (PIMS) in the form of an extension to ISO/IEC 27001.

Connect with us to accelerate market success!

info@longenesis.com

European Headquarters
Dzirnavu iela 41a-5,
Riga, Latvia
LV-1010

By clicking the button "Send" I confirm that I have read and accept the conditions outlined in the Privacy Policy.